Mesoporous Silica Nanoparticles for Drug Delivery and Catalysis
This research community develops porous silica structures, primarily mesoporous silica nanoparticles, to serve as carriers for controlled drug release and as supports for chemical catalysts.
The work centers on the synthesis and functionalization of mesoporous silica, often derived from biomass sources like rice husk ash. Key applications include controlled release systems for cancer therapy and other biomedical uses, alongside catalytic processes such as epoxidation and selective oxidation. Methods frequently involve sol-gel chemistry, core-shell architectures, and the integration of titanium into silica frameworks (titanium silicalite-1) to enhance catalytic activity. The community also investigates the safety, biological barriers, and surface modification of these nanoparticles to improve their efficacy in delivery systems.
Silicon research accounts for the largest share of this community's output, representing 1.2% of all silicon research tracked, with 4,468 papers in this group. The community publishes most frequently in Microporous and Mesoporous Materials, Langmuir, and Chemistry of Materials.
Recent work continues to focus on the synthesis and functionalization of mesoporous silica for drug delivery, including AI-guided design of nanocarriers for cancer therapy and silica platforms for nucleic acid delivery. Current research also explores rice-derived heterogeneous catalysts for green organic synthesis and the optimization of titanium silicalite-1 catalysts for selective oxidation reactions.